beta lapachone (MB-12066) / KT&G Corp  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
beta lapachone (MB-12066) / KT&G Corp
NCT01285388: Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers

Completed
1
50
NA
MB12066, beta-lapachone
Yungjin Pharm. Co., Ltd., KT&G Corporation
Metabolic Syndrome, Obesity
01/11
01/11
NCT01444677: Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers

Completed
1
40
RoW
MB12066, beta-lapachone, Placebo
Yungjin Pharm. Co., Ltd., KT&G Corporation
Metabolic Syndrome, Obesity
04/12
04/12
NCT02338856: Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Male Volunteers

Completed
1
11
RoW
MB12066 200mg, Placebo
Yungjin Pharm. Co., Ltd.
Metabolic Syndrome
02/15
02/15

Download Options